Rituximab biosimilar and reference rituximab in patients with previously untreated advanced follicular lymphoma (ASSIST-FL): primary results from a confirmatory phase 3, double-blind, randomised, controlled study.
W. Jurczak, I. Moreira, G. Kanakasetty, E. Munhoz +12 more

